Abstract
Background Combining immune checkpoint inhibitors (ICIs) with immunogenic chemotherapies is a promising approach in oesophageal adenocarcinoma (OAC) to convert ‘cold’ tumours to ‘hot’ tumours expanding the efficacy of ICIs to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have